Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H30O3 |
| Molecular Weight | 318.4504 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(O)C(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=RXXBBHGCAXVBES-XMUHMHRVSA-N
InChI=1S/C20H30O3/c1-18-9-8-16(21)17(22)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h12-14,22-23H,4-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1
| Molecular Formula | C20H30O3 |
| Molecular Weight | 318.4504 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://steroids.world/oranabol-oxymesterone
In men, a common clinical dose for oxymesterone was 20-40 mg per day. In the athletic arena, an effective oral daily dosage also falls in the range of 20-40 mg, taken in cycles lasting no more than 6-8 weeks to minimize hepatotoxicity.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:15:44 GMT 2025
by
admin
on
Mon Mar 31 18:15:44 GMT 2025
|
| Record UNII |
4R73K9MRMX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
||
|
NCI_THESAURUS |
C2360
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1208
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
72061
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
4R73K9MRMX
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
Oxymesterone
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
DTXSID80878527
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
205-646-9
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
m8334
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
C74112
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
2031
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
145-12-0
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
45048
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
100000083304
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
CHEMBL1908006
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY | |||
|
SUB09566MIG
Created by
admin on Mon Mar 31 18:15:44 GMT 2025 , Edited by admin on Mon Mar 31 18:15:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |